Chinese foothold in U.S. biotech is growing, USTR report finds

Despite recent efforts to crack down on foreign entities gaining access to U.S. IP and innovation through investment, Chinese VC investment in U.S. biotech is increasing, according to a report from the United States Trade Representative. The report singles out multiple VCs as contributing to the growth, including 6 Dimensions Capital, Oriza Holdings and Digital Horizon Capital (formerly Danhua Capital).